Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Sauter CS"" wg kryterium: Autor


Tytuł:
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
Autorzy:
Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Kumar A; Department of Internal Medicine, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Abutalib SA; Co-Director, Hematology & BMT/Cellular Therapy, Medical Director, NMDP Apheresis Midwest Program Associate Professor, Rosalind Franklin University of Medicine and Science, City of Hope, Zion, Illinois.
Awan FT; Division of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Chen YB; Hematopoietic Cell Transplant & Cell Therapy Program, Massachusetts General Hospital, Boston, Massachusetts.
Gopal AK; University of Washington/Fred Hutch Cancer Center, Seattle, Washington.
Holter-Chakrabarty J; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma.
Kekre N; Transplantation & Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada.
Lee CJ; Transplant and Cellular Therapy Program at Huntsman Cancer Institute, Salt Lake City, Utah.
Lekakis L; University of Miami, Miami, Florida.
Lin Y; Mayo Clinic, Rochester, Minnesota.
Mei M; City of Hope, Duarte, California.
Nathan S; Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, Illinois.
Nastoupil L; University of Texas, MD Anderson Cancer Center, Houston, Texas.
Oluwole O; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Phillips AA; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York.
Reid E; Moores Cancer Center at UC San Diego Health, La Jolla, California.
Rezvani AR; Division of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, California.
Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.
Zurko J; University of Wisconsin, Madison, Wisconsin.
Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, Florida.
Sauter CS; Division of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio.
Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
Carpenter PA; University of Washington/Fred Hutch Cancer Center, Seattle, Washington.
Hamadani M; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Sep; Vol. 29 (9), pp. 548-555. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Practice Guideline; Journal Article
MeSH Terms:
Receptors, Chimeric Antigen*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/therapy
Hematopoietic Stem Cell Transplantation*
Lymphoma, Non-Hodgkin*/drug therapy
Humans ; Neoplasm Recurrence, Local/drug therapy ; Rituximab/therapeutic use ; Cyclophosphamide/therapeutic use ; Vincristine/therapeutic use ; Prednisone/therapeutic use ; Doxorubicin/therapeutic use ; Recurrence
Czasopismo naukowe
Tytuł:
Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses.
Autorzy:
Maximova OA; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Weller ML; Secretory Physiology Section, Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States of America.
Krogmann T; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sturdevant DE; Research Technologies Branch, Genomics Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Ricklefs S; Research Technologies Branch, Genomics Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Virtaneva K; Research Technologies Branch, Genomics Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Martens C; Research Technologies Branch, Genomics Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Wollenberg K; Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Minai M; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Moore IN; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sauter CS; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
Barker JN; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Lipkin WI; Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Seilhean D; Sorbonne Université, Paris, France.
Nath A; Infections of the Nervous System Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America.
Cohen JI; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Aug 18; Vol. 19 (8), pp. e1011544. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Brain*
Astroviridae Infections*
Adult ; Humans ; Central Nervous System ; Neurons ; Immunity
Czasopismo naukowe
Tytuł:
Rush Hour Update: Roadblocks to CARs on the Expressway.
Autorzy:
Sauter CS; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jul; Vol. 29 (7), pp. 408-409.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Air Pollutants*/analysis
Particulate Matter/analysis
Czasopismo naukowe
Tytuł:
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant.
Autorzy:
Prockop SE; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.; Stem Cell Transplant Service, Division of Hematology/Oncology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Hasan A; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.
Doubrovina E; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.
Dahi PB; Stem Cell Transplant Service, Division of Hematology/Oncology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Rodriguez-Sanchez I; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.
Curry M; Department of Epidemiology and Biostatistics.
Mauguen A; Department of Epidemiology and Biostatistics.
Papanicolaou GA; Department of Pediatrics Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.; Infectious Disease Service, Department of Medicine, and.
Su Y; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.
Yao J; Department of Pathology, MSKCC, New York, New York, USA.
Arcila M; Department of Pathology, MSKCC, New York, New York, USA.
Boulad F; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
Castro-Malaspina H; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Cho C; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Curran KJ; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
Giralt S; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Kernan NA; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
Koehne G; Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.
Jakubowski A; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Papadopoulos E; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Politikos I; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Price K; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.
Selvakumar A; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.
Sauter CS; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Tamari R; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Vizconde T; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.
Young JW; Adult Bone Marrow Transplant Service, Department of Medicine, MSKCC, New York, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
O'Reilly RJ; Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, and.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2023 May 15; Vol. 133 (10). Date of Electronic Publication: 2023 May 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Cytomegalovirus Infections*/therapy
Cytomegalovirus Infections*/etiology
Humans ; Child ; Cytomegalovirus ; Viremia/therapy ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma.
Autorzy:
Fried S; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Shouval R; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address: .
Walji M; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Danylesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Tomas AA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; PhD Program in Signals Integration and Modulation in Biomedicine, Cellular Therapy, and Translational Medicine, University of Murcia, Murcia, Spain.
Fein JA; University of Connecticut Medical Center, Farmington, Connecticut.
Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sauter CS; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Kedmi M; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.
Jacoby E; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Shargian L; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikvah, Israel.
Raanani P; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikvah, Israel.
Yeshurun M; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikvah, Israel.
Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Feb; Vol. 29 (2), pp. 99-107. Date of Electronic Publication: 2022 Nov 05.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/epidemiology
Graft vs Host Disease*/etiology
Lymphoma, Large B-Cell, Diffuse*/therapy
Adult ; Humans ; Young Adult ; Middle Aged ; Aged ; Neoplasm Recurrence, Local/complications
Czasopismo naukowe
Tytuł:
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma.
Autorzy:
Nath K; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Tomas AA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; PhD Program in Signals Integration and Modulation in Biomedicine, Cell therapy and Translational Medicine, University of Murcia, Murcia, Spain.
Flynn J; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Fein JA; University of Connecticut Medical Center, Farmington, Connecticut.
Alperovich A; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Anagnostou T; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Batlevi CL; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Dahi PB; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Fingrut WB; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Giralt SA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Lin RJ; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Palomba ML; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Peled JU; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Salles G; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Sauter CS; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Scordo M; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Fraint E; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapies Program, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pediatric Hematology, Oncology and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York.
Feuer E; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Shah N; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Slingerland JB; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Devlin S; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Shah GL; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Gupta G; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Perales MA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Shouval R; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2022 Nov; Vol. 28 (11), pp. 751.e1-751.e7. Date of Electronic Publication: 2022 Aug 06.
Typ publikacji:
Observational Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*
Vitamin D Deficiency*/drug therapy
Adult ; Humans ; Vitamins/therapeutic use ; Vitamin D/therapeutic use ; Cell- and Tissue-Based Therapy
Czasopismo naukowe
Tytuł:
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation.
Autorzy:
Dahi PB; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: .
Lin A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York.
Scordo M; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Flynn JR; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Ruiz JD; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
DeRespiris L; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York.
Carlow D; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cho C; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Lahoud OB; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Sauter CS; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Boelens JJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Admiraal R; Department of Pediatrics, University Medical Center Utrecht, Utrecht, the Netherlands; Pediatric Blood and Marrow Transplantation Program, Princes Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Giralt SA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shah GL; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2022 Aug; Vol. 28 (8), pp. 485.e1-485.e6. Date of Electronic Publication: 2022 May 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/methods
Lymphoma*/drug therapy
Humans ; Melphalan/adverse effects ; Prospective Studies ; Transplantation, Autologous/methods
Czasopismo naukowe
Tytuł:
It is everywhere-A survey on the presence of carp edema virus in carp populations in Germany.
Autorzy:
Adamek M; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Heling M; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Bauer J; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Teitge F; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Bergmann SM; Institute of Infectology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Kleingeld DW; Lower Saxony State Office for Consumer Protection and Food Safety, Veterinary Task Force, Hannover, Germany.
Welzel A; Lower Saxony Ministry for Food, Agriculture and Consumer Protection, Hannover, Germany.
Scuda N; Bavarian Health and Food Safety Authority, Erlangen, Germany.
Bachmann J; Bavarian Animal Health Service, Nürnberg, Germany.
Louis CS; Institute of Epidemiology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Böttcher K; Saxony Animal Disease Fund, Dresden, Germany.
Bräuer G; Saxony Animal Disease Fund, Dresden, Germany.
Steinhagen D; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Jung-Schroers V; Fish Disease Research Unit, Institute for Parasitology, University of Veterinary Medicine, Hannover, Germany.
Pokaż więcej
Źródło:
Transboundary and emerging diseases [Transbound Emerg Dis] 2022 Jul; Vol. 69 (4), pp. 2227-2241. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carps*
Fish Diseases*/epidemiology
Poxviridae*/genetics
Poxviridae Infections*/epidemiology
Poxviridae Infections*/veterinary
Animals ; Edema/veterinary ; Germany/epidemiology ; Phylogeny ; Water
Czasopismo naukowe
Tytuł:
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation.
Autorzy:
Lin A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brown S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maloy M; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ruiz JD; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Devlin S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
DeRespiris L; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Proli A; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jakubowski AA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Papadopoulos EB; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Sauter CS; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Tamari R; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Castro-Malaspina H; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Shaffer B; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Barker J; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Giralt SA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Gyurkocza B; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jul; Vol. 63 (7), pp. 1686-1693. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Adrenal Cortex Hormones/adverse effects ; Humans ; Immunosuppressive Agents/adverse effects ; Methotrexate/adverse effects ; Mycophenolic Acid/adverse effects ; Transplantation Conditioning/methods
Czasopismo naukowe
Tytuł:
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.
Autorzy:
Savani M; Division of Hematology/Oncology, Department of Medicine, University of Arizona and University of Arizona Cancer Center, Tucson, Arizona, USA.
Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Chen Y; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Ahmed S; Division of Cancer Medicine, Departments of Lymphoma/Myeloma and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cashen AF; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Shadman M; Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Modi D; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.; Division of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Cutler CS; Department of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Zain J; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
Brammer JE; Division of Hematology, Department of Medicine, Ohio State University, Columbus, Ohio, USA.
Rezvani AR; Division of Blood & Marrow Transplantation, Department of Medicine, Stanford University, Stanford, California, USA.
Fenske TS; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Sauter CS; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.
Herrera AF; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
Hamadani M; Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2022 Apr; Vol. 197 (2), pp. 212-222. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Immunoblastic Lymphadenopathy*
Lymphoma, Large-Cell, Anaplastic*
Lymphoma, T-Cell, Peripheral*/therapy
Adolescent ; Adult ; Aged ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Retrospective Studies ; Transplantation Conditioning ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Tytuł:
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection.
Autorzy:
Shah N; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Dahi PB; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Ponce DM; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Sauter CS; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shaffer BC; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Chung DJ; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Politikos I; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Lin RJ; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Giralt SA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Papanicolaou G; Infectious Diseases, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Ramanathan LV; Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Kamboj M; Infectious Diseases, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shah GL; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Gyurkocza B; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2022 Jan; Vol. 28 (1), pp. 55.e1-55.e5. Date of Electronic Publication: 2021 Oct 11.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Hematopoietic Stem Cell Transplantation*
COVID-19 Testing ; Humans ; Retrospective Studies ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Autorzy:
Riedell PA; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, IL, USA.
Hamadani M; Department of Medicine, CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, USA.; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Ahn KW; Department of Medicine, CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
Litovich C; Department of Medicine, CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, USA.
Brunstein CG; Department of Medicine, Adult Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA.
Cashen AF; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.
Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Epperla N; Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA.
Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Im A; Division of Hematology/Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Inwards DJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Lister J; Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
McCarty JM; Bone Marrow Transplant Program, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Ravi Kiran Pingali S; Houston Methodist Cancer Center, Houston, TX, USA.
Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Medical Oncology Division, University of Washington, Seattle, WA, USA.
Shaughnessy P; Sarah Cannon Transplant and Cellular Therapy Program Methodist Hospital, San Antonio, TX, USA.
Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USA.
Stiff PJ; Department of Medicine, Loyola University Medical Center, Maywood, IL, USA.
Vose JM; Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
Sauter CS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Smith SM; Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2021 Dec; Vol. 195 (5), pp. 757-763. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Lymphoma, Mantle-Cell/*therapy
Adult ; Aged ; Female ; Humans ; Lymphoma, Mantle-Cell/diagnosis ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Retrospective Studies ; Survival Analysis ; Time Factors ; Transplantation, Autologous
Czasopismo naukowe
Tytuł:
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.
Autorzy:
Riedell PA; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois.
Hamadani M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: .
Ahn KW; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
Litovich C; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Murthy GSG; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
Brunstein CG; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Masachusetts.
Stiff PJ; Division of Hematology-Oncology, Department of Medicine, Loyola University Stritch School of Medicine, Maywood, Illinois.
Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
Sauter CS; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Smith SM; Division of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Nov; Vol. 27 (11), pp. 911.e1-911.e7. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Lymphoma, Mantle-Cell*/therapy
Adolescent ; Adult ; Aged ; Humans ; Retrospective Studies ; Transplantation Conditioning ; Transplantation, Autologous
Czasopismo naukowe
Tytuł:
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.
Autorzy:
Epstein-Peterson ZD; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ganesan N; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Barker JN; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Drullinsky PR; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Ghione P; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jakubowski AA; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Kumar A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Moskowitz AJ; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Noy A; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Perales MA; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Ponce DM; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Schoder H; Weill Cornell Medical College, New York, NY, USA.; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Young JW; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Giralt SA; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Horwitz SM; Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Sauter CS; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Dahi PB; Adult BMT Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Sep; Vol. 62 (9), pp. 2177-2183. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Human T-lymphotropic virus 1*
Leukemia-Lymphoma, Adult T-Cell*/diagnosis
Leukemia-Lymphoma, Adult T-Cell*/therapy
Lymphoma*
Disease-Free Survival ; Humans
Czasopismo naukowe
Tytuł:
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma.
Autorzy:
Munshi PN; Department of Blood and Marrow Transplantation, MedStar Georgetown University Hospital, Washington, DC.
Hamadani M; Center for International Blood & Marrow Transplant Research and the BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: .
Kumar A; Department of Internal Medicine, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Dreger P; Department of Medicine, University of Heidelberg, Germany.
Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, New York.
Dreyling M; Department of Medicine III, LMU Hospital Munich, Munich, Germany.
Kahl B; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Jerkeman M; Department of Oncology, Skane University Hospital, Lund University, Lund, Sweden.
Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, Florida.
Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
Shadman M; Blood and Marrow Transplantation Program, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington.
Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Ahmed S; Department of Lymphoma, Myeloma and Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.
Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California.
Sauter CS; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Ghosh N; Levine Cancer Institute, Atrium Health, Charlotte, Nnorth Carolina.
Lunning M; Divsion of Hematology and Oncology, University of Nebraska Medical Center, Omaha, Nebraska.
Kenkre VP; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Aljurf M; Blood and Marrow Transplantation Program, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Wang M; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
Maddocks KJ; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Leonard JP; Department of Medicine, Weill Cornell Medicine, New York, New York.
Kamdar M; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, Colorado.
Phillips T; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Cashen AF; Division of Oncology, Section of Stem Cell Transplantation, Washington University School of Medicine, St Louis, Missouri.
Inwards DJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Sureda A; Clinical Hematology Department, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge IDIBELL, Universitat de Barcelona, Barcelona, Spain.
Cohen JB; Winship Cancer Institute, Atlanta, Georgia.
Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
Carlo-Stella C; Department of Biomedical Sciences, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy.
Savani B; Blood and Marrow Transplantation Program, Vanderbilt University Medical Center, Nashville, Tennessee.
Robinson SP; University Hospital Bristol NHS Foundation Trust, London, United Kingdom.
Fenske TS; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Sep; Vol. 27 (9), pp. 720-728.
Typ publikacji:
Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Lymphoma, Mantle-Cell*/therapy
Adult ; Bone Marrow ; Humans ; Neoplasm Recurrence, Local ; Transplantation Conditioning ; United States
Czasopismo naukowe
Tytuł:
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.
Autorzy:
Nawas MT; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Shah GL; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Feldman DR; Department of Medicine, Weill Cornell Medical College, New York, New York.; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Ruiz JD; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Robilotti EV; Department of Medicine, Weill Cornell Medical College, New York, New York.; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York.
Aslam AA; Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York.
Dundas M; Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York.
Kamboj M; Department of Medicine, Weill Cornell Medical College, New York, New York.; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York.
Barker JN; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Cho C; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Chung DJ; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Dahi PB; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Giralt SA; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Gyurkocza B; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Lahoud OB; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Landau HJ; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Lin RJ; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Mailankody S; Department of Medicine, Weill Cornell Medical College, New York, New York.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Palomba ML; Department of Medicine, Weill Cornell Medical College, New York, New York.; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Papadopoulos EB; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Politikos I; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Ponce DM; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Sauter CS; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shaffer BC; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Scordo M; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
van den Brink MRM; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Perales MA; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Tamari R; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 May; Vol. 27 (5), pp. 438.e1-438.e6. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
COVID-19*/complications
COVID-19*/epidemiology
COVID-19*/transmission
Hematopoietic Stem Cell Transplantation*/statistics & numerical data
Immunotherapy, Adoptive*
Pandemics*
SARS-CoV-2*
Time-to-Treatment*/statistics & numerical data
Adult ; Aged ; Allografts ; Amyloidosis/therapy ; Anemia, Aplastic/therapy ; Civil Defense ; Cross Infection/epidemiology ; Cross Infection/prevention & control ; Disease Progression ; Evidence-Based Practice/organization & administration ; Female ; Humans ; Infection Control/methods ; Infectious Disease Transmission, Professional-to-Patient ; Leukemia/mortality ; Leukemia/pathology ; Leukemia/therapy ; Male ; Middle Aged ; Myelodysplastic-Myeloproliferative Diseases/mortality ; Myelodysplastic-Myeloproliferative Diseases/therapy ; Neoplasm, Residual ; Neoplasms/mortality ; Neoplasms/therapy ; New York City/epidemiology ; Resource Allocation ; Transplantation, Autologous ; Triage/organization & administration ; Young Adult
Czasopismo naukowe
Tytuł:
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
Autorzy:
Garcia-Recio M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Wudhikarn K; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Hematology and Research Unit in Translational Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pennisi M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Oncology and Onco-Hematology Department, University of Milan, Milan, Italy; Hematology Service, Oncology and Hematology Department, Instituto Nazionale dei Tumori, Milan, Italy.
Alonso-Trillo R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematology Service, Hospital Puerta de Hierro, Majadahonda, Spain.
Flynn J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Shouval R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Afuye AO; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Silverberg ML; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Batlevi CW; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Dahi P; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Devlin S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Halton E; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Ruiz J; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Maloy M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Mead E; Neurology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Palomba ML; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Santomasso B; Neurology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Sauter CS; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Intensive Care Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Mar; Vol. 27 (3), pp. 233-240. Date of Electronic Publication: 2020 Dec 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/therapy
Receptors, Chimeric Antigen*
Cell- and Tissue-Based Therapy ; Humans ; Immunotherapy, Adoptive ; Prognosis
Czasopismo naukowe
Tytuł:
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Autorzy:
Lin RJ; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Lobaugh SM; Dept. of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Pennisi M; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Chan HT; Adult BMT Service, Memorial Sloan Kettering Cancer Center.
Batlevi Y; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Ruiz JD; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Elko TA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Maloy MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Batlevi CL; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Dahi PB; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Giralt SA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Hamlin PA; Critical Care Service, Memorial Sloan Kettering Cancer Center, New York, USA.
Mead E; Critical Care Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Noy A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Palomba ML; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York.
Santomasso BD; Neurology Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Sauter CS; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Scordo M; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Shah GL; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Korc-Grodzicki B; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Kim SJ; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Silverberg ML; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Brooklyn CA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Devlin SM; Dept. of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Perales MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 255-258. Date of Electronic Publication: 2021 Jan 01.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/therapy
Receptors, Chimeric Antigen*/genetics
Aged ; Antigens, CD19 ; Cell- and Tissue-Based Therapy ; Humans ; Immunotherapy, Adoptive ; Receptors, Antigen, T-Cell/genetics
Raport
Tytuł:
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma.
Autorzy:
Wudhikarn K; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Hematology and Research Unit in Translational Hematology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand.
Palomba ML; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Pennisi M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Hematology, Oncology and Hemato-Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.
Garcia-Recio M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Afuye A; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Silverberg ML; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maloy MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Dahi PB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Sauter CS; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Batlevi CL; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Santomasso BD; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mead E; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Seo SK; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. .
Pokaż więcej
Źródło:
Blood cancer journal [Blood Cancer J] 2020 Aug 05; Vol. 10 (8), pp. 79. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, CD19/*immunology
Immunotherapy, Adoptive/*adverse effects
Infections/*etiology
Lymphoma, Large B-Cell, Diffuse/*therapy
Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents/therapeutic use ; Female ; Humans ; Immunotherapy, Adoptive/methods ; Incidence ; Infections/immunology ; Infections/therapy ; Lymphoma, Large B-Cell, Diffuse/immunology ; Male ; Middle Aged ; Risk Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies